Paul S. Covington

Filings by Paul S. Covington span 2 companies, the busiest being Pharmaceutical Product Development Inc and Furiex Pharmaceuticals, Inc. We count 93 filings; the first trade dates from 31 December 2005 and the latest from 2 July 2014.

Market trades split into 1 purchase (€38k) and 72 sales (€10.4M). The net balance comes to €10.4M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 share grants and 11 option exercises. So far in 2014, the count stands at no purchases and 4 sales.

The record was last updated on 7 July 2014 with a transaction in Furiex Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 5,435 days ago, on 7 December 2011. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.